Balchem Corporation  

(Public, NASDAQ:BCPC)   Watch this stock  
Find more results for BCPC
32.73
0.00 (0.00%)
Aug 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 26.56 - 43.84
Open     -
Vol / Avg. 0.00/100,334.00
Mkt cap 957.78M
P/E 25.35
Div/yield 0.18/0.55
EPS 1.29
Shares 29.26M
Beta 0.73
Inst. own 75%
Aug 1, 2012
Q2 2012 Balchem Corp Earnings Conference Call
Aug 1, 2012
Q2 2012 Balchem Corp Earnings Release
Jun 14, 2012
Balchem Corp Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 12.16% 13.28%
Operating margin 17.95% 19.26%
EBITD margin - 22.45%
Return on average assets 13.52% 15.50%
Return on average equity 15.64% 18.48%
Employees 365 -
Carbon Disclosure Rating - -

Address

52 Sunrise Park Road
NEW HAMPTON, NY 10958
United States - Map
+1-845-3265600 (Phone)
+1-845-3265742 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Balchem Corporation (Balchem) is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company has three reportable segments: Specialty Products, Food, Pharma & Nutrition, and Animal Nutrition & Health. The Company sells its products through its own sales force, independent distributors and sales agents. The Company operates five wholly owned domestic subsidiaries, such as BCP Ingredients, Inc., Aberco, Inc., Balchem BV, Balchem Trading BV and Balchem Italia Srl. The Food, Pharma & Nutrition (FPN) segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance performance of nutritional fortification, processing, mixing, and packaging applications and shelf-life. Balchem�s Specialty Products segment operates in industry as ARC Specialty Products.

Officers and directors

Dino A. Rossi Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation - Reuters
Francis J. Fitzpatrick CPA Chief Financial Officer, Treasurer, Assistant Secretary
Age: 51
Bio & Compensation - Reuters
William A. Backus CPA Chief Accounting Officer, Assistant Treasurer
Age: 45
Bio & Compensation - Reuters
David F. Ludwig Vice President, General Manager - Specialty Products
Age: 54
Bio & Compensation - Reuters
Matthew D. Houston General Counsel, Secretary
Age: 48
Bio & Compensation - Reuters
John Y. Televantos Ph.D. Lead Independent Director
Age: 59
Bio & Compensation - Reuters
Paul D. Coombs Independent Director
Age: 56
Bio & Compensation - Reuters
David B. Fischer Independent Director
Age: 49
Bio & Compensation - Reuters
Edward L. McMillan Independent Director
Age: 66
Bio & Compensation - Reuters
Perry W. Premdas Independent Director
Age: 59
Bio & Compensation - Reuters